Skip to content
GenoLensGenoLens

PTPN13

Chr 4q21.3

protein tyrosine phosphatase non-receptor type 13

Aliases:
PTP1E, PTP-BAS, PTPL1, PTP-BL
MANE:
ENST00000411767.7

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Haematological malignancies cancer susceptibility

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • pancreatic ductal adenocarcinoma

    0.37
  • gastric carcinoma

    0.37
  • endometrial endometrioid adenocarcinoma

    0.37
  • ovarian endometrioid adenocarcinoma with squamous differentiation

    0.37
  • kidney neoplasm

    0.37
  • Transitional Meningioma

    0.37
  • skin basal cell carcinoma

    0.37
  • hemangioblastoma

    0.37
  • carcinoma of liver and intrahepatic biliary tract

    0.37
  • Atypical Meningioma

    0.37

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Tyrosine-protein phosphatase non-receptor type 13

Tyrosine phosphatase which negatively regulates FAS-induced apoptosis and NGFR-mediated pro-apoptotic signaling (PubMed:15611135). May regulate phosphoinositide 3-kinase (PI3K) signaling through dephosphorylation of PIK3R2 (PubMed:23604317)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.